Parkman-Healthcare-Partners

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
91
Total Value
843125283
Accession Number
0001420506-25-001258
Form Type
13F-HR
Manager Name
Parkman-Healthcare-Partners
Data Enrichment
97% identified
88 identified3 unidentified

Holdings

91 positions • $843.1M total value
Manager:
Search and click to pin securities to the top
Vaxcyte, Inc.
Shares:93.4K
Value:$3.5M
% of Portfolio:0.4% ($3.5M/$843.1M)
SI-BONE, Inc.
Shares:231.1K
Value:$3.2M
% of Portfolio:0.4% ($3.2M/$843.1M)
UNITED THERAPEUTICS Corp
Shares:10.2K
Value:$3.2M
% of Portfolio:0.4% ($3.2M/$843.1M)
45779A846
Shares:1.2M
Value:$3.2M
% of Portfolio:0.4% ($3.2M/$843.1M)
Performant Healthcare Inc
Shares:1.1M
Value:$3.1M
% of Portfolio:0.4% ($3.1M/$843.1M)
DYNAVAX TECHNOLOGIES CORP
Shares:234.8K
Value:$3.0M
% of Portfolio:0.4% ($3.0M/$843.1M)
INSMED Inc
Shares:37.9K
Value:$2.9M
% of Portfolio:0.3% ($2.9M/$843.1M)
ARTIVION, INC.
Shares:111.7K
Value:$2.7M
% of Portfolio:0.3% ($2.7M/$843.1M)
Terns Pharmaceuticals, Inc.
Shares:959.7K
Value:$2.6M
% of Portfolio:0.3% ($2.6M/$843.1M)
690145206
Shares:231.1K
Value:$2.6M
% of Portfolio:0.3% ($2.6M/$843.1M)
MBX Biosciences, Inc.
Shares:328.3K
Value:$2.4M
% of Portfolio:0.3% ($2.4M/$843.1M)
Keros Therapeutics, Inc.
Shares:217.8K
Value:$2.2M
% of Portfolio:0.3% ($2.2M/$843.1M)
uniQure N.V.
Shares:203.8K
Value:$2.2M
% of Portfolio:0.3% ($2.2M/$843.1M)
Crinetics Pharmaceuticals, Inc.
Shares:63.9K
Value:$2.1M
% of Portfolio:0.3% ($2.1M/$843.1M)
NewAmsterdam Pharma Co N.V.
Shares:101.0K
Value:$2.1M
% of Portfolio:0.2% ($2.1M/$843.1M)
RAPID MICRO BIOSYSTEMS, INC.
Shares:735.6K
Value:$1.9M
% of Portfolio:0.2% ($1.9M/$843.1M)
Vera Therapeutics, Inc.
Shares:76.1K
Value:$1.8M
% of Portfolio:0.2% ($1.8M/$843.1M)
Apogee Therapeutics, Inc.
Shares:46.7K
Value:$1.7M
% of Portfolio:0.2% ($1.7M/$843.1M)
ICAD INC
Shares:781.7K
Value:$1.6M
% of Portfolio:0.2% ($1.6M/$843.1M)
MARAVAI LIFESCIENCES HOLDINGS, INC.
Shares:660.0K
Value:$1.5M
% of Portfolio:0.2% ($1.5M/$843.1M)